Program
Schedule
As of August 23, 2024 (*tentative)
Program
Educational Programme Opening Remarks
Sep 12（Thu.）10:25-10:30Room2
- Prof. Ichizo Nishino（National Center of Neurology and Psychiatry, Japan）
Educational Programme 1
Sep 12（Thu.）10:30-12:00Room2
- Chair
- Dr. Sara Khan（Aga Khan University Hospital, Pakistan）
- Dr. Kazuma Sugie（Nara Medical University, Japan）
- Dr. Wen-Chen Liang（Kaohsiung Medical University Hospital, Taiwan）
- Prof. Hui Xiong（Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, China）
- Prof. Atchayaram Nalini（National Institute of Mental Health and Neurosciences, India）
EP1-1How to examine infants suspected to have neuromuscular disorders
EP1-2Characteristics, natural history and management of LAMA2-related dystrophies: A multi-cohort study from the Asian-Oceanian Network
EP1-3Examination of an adult patient with Muscle and Neuromuscular junctions disorders
Educational Programme 2
Sep 12（Thu.）13:10-14:40Room2
- Chair
- Dr. Chongbo Zhao（Huashan Hospital, Fudan University, China）
- Dr. Rajesh Benny（Fortis Hospital, India）
- Prof. Satish V. Khadilkar（Bombay Hospital Institute of Medical Sciences, India）
- Prof. Kinji Ohno（Nagoya University Graduate School of Medicine, Japan）
- Prof. Teerin Liewluck（Mayo Clinic-Rochester, USA）
EP2-1Making Sense of the Clinical spectrum of Limb Girdle Muscular Dystrophies
EP2-2Congenital myasthenic syndromes: Review of 38 causal genes
EP2-3The expanding genetic landscape of hereditary rhabdomyolysis: what clinicians need to know
Educational Programme 3
Sep 12（Thu.）14:50-16:20Room2
- Chair
- Dr. Katsuhisa Ogata（National Hospital Organization Higashisaitama Hospital, Japan）
- Dr. Anna Cho（Seoul National University Bundang Hospital, Korea）
- Dr. Kimiko Inoue（National Hospital Organization Osaka Toneyama Medical Center, Japan）
- Dr. Yuka Ishikawa（National Hospital Organization Hokkaido Medical Center, Japan）
- Dr. Atsuhito Takeda（Hokkaido University Graduate School of Medicine, Japan）
EP3-1Rehabilitation for progressive neuromuscular disorders: focus on Duchenne muscular dystrophy
EP3-2Pulmonary rehabilitation and management of dysphagia in patients with neuromuscular disorders
EP3-3Pathophysiology and management of cardiomyopathy associated with neuromuscular disease
Educational Programme 4
WMS Collaborate session
Sep 12（Thu.）16:30-18:00Room2
- Chair
- Dr. Wen-Chen Liang（Kaohsiung Medical University Hospital, Taiwan）
- A/Prof. Gina Ravenscroft（University of Western Australia, Australia）
- Prof. Jordi Alberto Diaz-Manera（Newcastle University, UK）
- Prof. Werner Stenzel（Charite University Hospital, Germany）
- Prof. Alessandra Ferlini（University of Ferrara, Italy）
EP4-1Muscle Imaging
EP4-2Differential diagnosis of IBM
EP4-3Genetic diagnosis of muscle diseases: from gene-by-gene testing through next generation sequencing toward genomic medicine
Opening Ceremony
Sep 13（Fri.）8:30-9:00Room1
- Chair
- Prof. Ichizo Nishino（National Center of Neurology and Psychiatry, Japan）
Keynote Lecture 1
Sep 13（Fri.）9:10-10:40Room1
- Chair
- Prof. Yoshihide Sunada（Kawasaki Medical School, Japan）
- Prof. Ichizo Nishino（National Center of Neurology and Psychiatry, Japan）
- Prof. Michio Hirano（Columbia University Irving Medical Center, USA）
K-1Emerging Therapies for Thymidine Phosphorylase and Thymidine Kinase 2 Deficiencies
Keynote Lecture 2
Sep 13（Fri.）9:10-10:40Room1
- Chair
- Satish V. Khadilkar（Bombay Hospital Institute of Medical Sciences）
- Dr. Kazuma Sugie（Nara Medical University, Japan）
- Dr. Yoshitsugu Aoki（National Center of Neurology and Psychiatry, Japan）
K-2
Symposium 1 [AOMC-TREAT-NMD collaboration]
Clinical trials in NMD- Challenges we face
Sep 13（Fri.）10:50-12:20Room1
- Chair
- Prof. Dae-Seong Kim（Pusan National University Yangsan Hospital, Korea）
- Prof. Yukiko K. Hayashi（Tokyo Medical University, Japan）
- Prof. Annemieke Aartsma-Rus（Leiden University Medical Center, Netherlands）
- Prof. Alessandra Ferlini（University of Ferrara, Italy）
- Prof. Masanori Takahashi（Osaka University, Japan）
S1-1The importance of involving patients in therapy development
Lessons learned from Duchenne exon skipping
Lessons learned from Duchenne exon skipping
S1-2Therapeutic approaches in Duchenne muscular dystrophy: fall, rise, and challenges
S1-3Clinical Trial Readiness in Myotonic Dystrophy
Symposium 2
Link between Research, Clinical trials, and Patient registries
Sep 13（Fri.）13:30-15:00Room1
- Chair
- Prof. Sophelia Hoi-Shan Chan（The University of Hong Kong, Hong Kong SAR, China）
- Dr. Yuko Shimizu-Motohashi（National Center of Neurology and Psychiatry, Japan）
- Prof. Jong-Hee Chae（Seoul National University College of Medicine, Korea）
- Prof. Oranee Sanmaneechai（Mahidol University, Thailand）
- Prof. Sophelia Hoi-Shan Chan（The University of Hong Kong, Hong Kong SAR, China）
- Dr. Yuko Shimizu-Motohashi（National Center of Neurology and Psychiatry, Japan）
S2-1Current status in South Korea: From patients registry to Clinical trials
S2-2Interconnection between Research, Clinical Trials, and Neuromuscular Patient Registries in Thailand
S2-3Advancements in FSHD Research: Insights from the Hong Kong FSHD Patient Registry and Innovative AI Applications
S2-4Congenital muscular dystrophies and myopathies: Current status in Japan
Symposium 3
Myositis (tentative)
Sep 13（Fri.）15:10-16:40Room1
- Chair
- Dr. Akinori Uruha（Tokyo Metropolitan Neurological Hospital, Japan）
- Dr. Jantima Tanboon（Mahidol University, Thailand）
- Prof. Werner Stenzel（Charite University Hospital, Germany）
- Dr. Jantima Tanboon（Mahidol University, Thailand）
- Prof. Tahseen Mozaffer（University of California, Irvine, USA）
- Prof. Wei Wang（Huazhong University of Science and Technology, China）
- Prof. Satoshi Yamashita（International University of Health and Welfare Narita Hospital, Japan）
- Prof. Naoko Okiyama（Tokyo Medical and Dental University, Japan）
S3-1Myositis classification and pathology: an update (Part 1)
S3-2Myositis classification and pathology: an update (Part 2) Dermatomyositis, Antisynthetase syndrome, and a few others
S3-3Update on Muscle Imaging in Idiopathic Inflammatory Myopathy (IIM)
S3-4Single-cell analysis of refractory anti-SRP necrotizing myopathy treated with anti-BCMA CAR T-cell therapy
S3-5Unlocking the Mystery: The Pathogenic Role of Anti-cN1A Antibodies in Inclusion Body Myositis
S3-6Autoimmunity against melanoma differentiation-associated gene 5 induces interstitial lung disease mimicking dermatomyositis in mice
Symposium 4
Current Status of the Neuromuscular Field in New Member and Expected-to-be New Member Countries
Sep 13（Fri.）16:50-18:20Room1
- Chair
- Prof. Umapathi Thirugnanam（National Neuroscience Institute, Singapore）
- Dr. Ohnmar（Yangon General Hospital/University of Medicine 1, Myanmar）
- Dr. Si Tri Le（University Medical Center of Hochiminh, Vietnam）
- Prof. Abdulnasir Hassin Am（Alhadi Neuromuscular Diseases Center, Iraq）
- Dr. Altynshash Jaxybayeva（Astana Medical University, Kazakhstan）
- Dr. Sanjaya Fernando（Ministry of Health Sri Lanka）
- Dr. Esmatullah Hamed（French Medical University for Mothers and Children, Afghanistan）
S4-1An Overview of Myology in Vietnam: From AOMC 2017 to the Present
S4-2Challenges and lessons learnt in setting up clinical, eletrodiagnostic and pathologic services for neuromuscular diseases in Iraq
S4-3Management of neuromuscular diseases in Kazakhstan
S4-4Emerging from the ashes and founding myology services in Sri Lanka
S4-5Neurological Care in Afghanistan with 40 million population faces a rising neurological disease burden, including encephalitis, meningitis, malaria, measles and stroke. Neurological care is limited, with only two neurologists trained at The Aga Khan University. Challenges include poor awareness, inadequate training, and financial constraints. FMIC is working to improve services and establish a residency program.
Symposium 5
Recent advances in sarcopenia and frailty studies
Sep 13（Fri.）16:50-18:20Room2
- Chair
- Prof. Akiyoshi Uezumi（Kyushu University, Japan）
- Dr. Satoru Noguchi（National Instituteof Neuroscience, National Center of Neurology and Psychiatry, Japan）
- Prof. Dr. Hidenori Arai（National Center for Geriatrics and Gerontology, Japan）
- Prof. Hiroshi Asahara（Tokyo Medical and Dental University, Japan）
- Prof. Tatsuya Yoshizawa（Kyoto Prefectural University of Medicine, Japan）
- Dr. Tatsuya Hosoi（The University of Tokyo, Japan）
S5-1Research update of sarcopenia in Asia
S5-2Athlete Giftedness and Genetics
S5-3The diverse functions of NAD-dependent lysine deacylase SIRT7 in the musculoskeletal systems.
S5-4The Androgen-Androgen Receptor Signaling in skeletal muscle: Insights into the Mechanisms of Sarcopenia Development and Potential Aging Regulation
Symposium 6
Muscle atrophy and hypertrophy (tentative)
Sep 14（Sat.）9:00-10:30Room1
- Chair
- Dr. Masaki Inada（Tokyo University of Agriculture and Technology, Japan）
- Dr. Naoki Suzuki（Tohoku University, Japan）
- Prof. Satoru Takahashi（University of Tsukuba, Japan）
- Prof. Dr. Masaki Inada（Tokyo University of Agriculture and Technology, Japan）
- Prof. Dr. Hirohiko Hohjoh（Graduate School of Medicine, Juntendo University, Japan）
- Dr. Yuki Saito（Sapporo Medical Universiry, Japan）
S6-1Elucidation of Skeletal Muscle Regulation Mechanisms Using Mouse Space Experiments
S6-2Differential gene responses for slow-twitch and fast-twitch muscles in muscular atrophy and hypertrophy.
S6-3MicroRNA199 is involved in muscle differentiation and muscle hypertrophy
S6-4Diverse roles of cellular senescence in skeletal muscle inflammation and regeneration
Symposium 7
Muscle stem cells in regeneration and homeostasis
Sep 14（Sat.）10:40-12:10Room1
- Chair
- Dr. Shinichiro Hayashi（National Institute of Neuroscience, National Center of Neurology and Psychiatry, Japan）
- Prof. So-ichiro Fukada（Graduate School of Pharmaceutical Sciences, Osaka University, Japan）
- Prof. So-ichiro Fukada（Graduate School of Pharmaceutical Sciences, Osaka University, Japan）
- Prof. Yuji Hara（School of Pharamaceutical Sciences, University of Shizuoka, Japan）
- Prof. Yusuke Ono（Institute of Molecular Embryology and Genetics (IMEG), Kumamoto University, Japan）
- Assoc. prof. Hidetoshi Sakurai（Center for iPS Research and Application (CiRA), Kytoto University, Japan）
S7-1Molecular mechanisms regulating behaviors of muscle satellite cells in response to intrinsic and extrinsic factors
S7-2Role of mechanosensitive ion channels during myofiber regeneration
S7-3Functional heterogeneity in the activated satellite cell population
S7-4Development of Cell Therapy for DMD by iPSC-derived Muscle Stem Cell (iMuSC)
Symposium 8
Muscle Mechanosensing and Metabolic Dynamics during Physical Activities
Sep 14（Sat.）13:30-15:00Room1
- Chair
- Dr. Takashi Yamada（Sapporo Medical University, Japan）
- Dr. Norio Motohashi（National Center of Neurology and Psychiatry, Japan）
- Dr. Naoki Ito（National Center for Geriatrics and Gerontology, Japan）
- Dr. Ayaka Tabuchi（The University of Electro-Communications, Japan）
- Dr. Kohei Kido（National Institute of Advanced Industrial Science and Technology, Japan）
- Dr. Yasuhiro Sawada（National Rehabilitation Center for Persons with Disabilities, Japan）
S8-1Age-related dysfunction of NAD+ metabolism and Ca2+ signaling in skeletal muscle as a cause of anabolic resistance
S8-2in vivo intracellular calcium ion dynamics regulating exercise-induced muscle damage: Spatio-temporal characteristics and its underlying mechanism
S8-3Intramuscular Regulation of Post-Exercise Glucose Clearance
S8-4Deciphering the mechanisms underlying the positive effects of exercise on organismal homeostasis from mechanobiological perspectives, thereby developing novel therapeutic/preventative strategies for a variety of diseases and disorders
Symposium 9
Treatable NMD (tentative)
Sep 14（Sat.）13:30-15:00Room2
- Chair
- Prof. Khean-Jin Goh（University of Malaya, Malaysia）
- Dr. Sara Khan（Aga Khan University Hospital, Pakistan）
- Prof. Chuanzhu Yan（Qilu Hospital, Shandong University, China）
- Dr. Akinori Uruha（Tokyo Metropolitan Neurological Hospital, Japan）
- Dr. Hirofumi Komaki（National Center of Neurology and Psychiatry, Japan）
- Prof. Yuh-Jyh Jong（Kaohsiung Medical University Hospital, Taiwan）
S9-1State of the art in lipid storage myopathy
S9-2Current landscape of sporadic late-onset nemaline myopathy
S9-3Gene-Targeted Therapy for Duchenne Muscular Dystrophy: Clinical Development Update
S9-4Challenges and Opportunities in the Treatment of Spinal Muscular Atrophy
Symposium 10
Perspectives on skeletal muscle and organ interactions in homeostasis and disease
Sep 14（Sat.）15:10-16:40Room1
- Chair
- Dr. Keisuke Hitachi（Fujita Health University, Japan）
- Dr. Tomoya Uchimura（Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan）
- Dr. Naoomi Tominaga（Yamaguchi University, Japan）
- Dr. Naoyuki Kawao（Kindai University Faculty of Medicine, Japan）
- Dr. Koji Ohashi（Nagoya University, Japan）
- Prof. Chihiro Tohda（University of Toyama, Japan）
S10-1The role of ｍuscle-derived extracellular vesicles in aging.
S10-2Crosstalk between skeletal muscle and bone
S10-3The role of exercise-induced myokines in cardiovascular homeostasis
S10-4Skeletal muscle atrophy-induced cognitive dysfunction: its mechanism and protective strategy
Symposium 11
Other myopathy (tentative)
Sep 14（Sat.）15:10-16:40Room2
- Chair
- Prof. Raymond L. Rosales（University of Santo Tomas, Philippines）
- Dr. Charungthai Dejthevaporn（Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand）
- Dr. Matthew Watts（Ministry of Health & University of Sydney, Australia）
- Prof. Teerin Liewluck（Mayo Clinic-Rochester, USA）
- Dr. Michio Inoue（Washington University School of Medicine, USA）
- Assoc. Prof. Gina Ravenscroft（University of Western Australia, Australia）
- Prof. Jordi Alberto Diaz-Manera（Newcastle University, UK）
S11-1Anncaliia algerae infection: potentially fatal, unclear epidemiology.
S11-2Electrodiagnostic and myopathologic correlation in critical illness myopathy.
S11-3Muscle Chaperonopathies: From Clinical Presentation to Molecular Mechanisms
S11-4Ten years of disease gene discovery and diagnostics in neurogenetic diseases
S11-5VCP Myopathy
Symposium 12
Advancing Next-Generation Therapeutic Modalities for Muscular Disorders
Sep 15（Sun.）9:00-10:30Room1
- Chair
- Dr. Yoshitsugu Aoki（National Center of Neurology and Psychiatry, Japan）
- Dr. Masayuki Nakamori（Yamaguchi University, Japan）
- Prof. Takashi Okada（The Institute of Medical Science, The University of Tokyo, Japan）
- Dr. Masayuki Nakamori（Yamaguchi University, Japan）
- Prof. Motoi Kanagawa（Ehime University, Japan）
- Prof. Shinichi Nakagawa（Hokkaido University, Japan）
S12-1Development of immune tolerance-inducing gene therapy using mesenchymal cells
S12-2Pentatricopeptide repeat protein targeting CUG repeat RNA ameliorates RNA toxicity in myotonic dystrophy type 1
S12-3CDP-ribitol prodrug treatment ameliorates ISPD-deficient muscular dystrophy
S12-4Exon skipping therapy using a novel chimeric RNA fused with 4.5SH
Symposium 13
New technologies and models to facilitate muscle research
Sep 15（Sun.）10:40-12:10Room1
- Chair
- Dr. Hiroaki Mitsuhashi（Department of Bioengineering, School of Engineering, Tokai University, Japan）
- Dr. Ai Shima（The University of Tokyo, Japan）
- Dr. Akitsu Hotta（Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan）
- Dr. Yukari Endo（Juntendo University, Japan）
- Dr. Hironobu Takahashi（Tokyo Women’s Medical University, Japan）
- Dr. Tomoya Uchimura（Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan）
S13-1Skeletal muscle delivery tools of CRISPR-Cas genome editing
S13-2Investigating and Developing Treatments for Triadopathies Using Zebrafish Pre-Clinical Models
S13-3Production of human muscle tissues based on cell sheet-based tissue engineering
S13-4Disease modeling of Duchenne muscular dystrophy for the functional analyses by muscle training using patient-derived iPSC in vitro.
JSNP Joint Symposium
Pathomechanism of OPDM and related disorders
Sep 14（Sat.）16:50-18:50Room1
- Chair
- Dr. Takashi Kurashige（NHO Kure Medical Center and Chugoku Cancer Center, Japan）
- Dr. Jun Sone（Aichi Medical University, Japan）
- Prof. Hiroyuki Ishiura（Okayama University, Japan）
- Dr. Takashi Kurashige（NHO Kure Medical Center and Chugoku Cancer Center, Japan）
- Prof. Norifumi Shioda（Institute of Molecular Embryology and Genetics (IMEG), Kumamoto University, Japan）
- Dr. Masashi Ogasawara（Showa General Hospital, Japan）
- Dr. Jun Sone（Aichi Medical University, Japan）
- Dr. Rie Saito（Brain Research Institute, Niigata University, Japan）
Noncoding repeat expansions in OPDM and related disorders and their mechanisms
RAN translation and RNA foci: Causing differentiation of phenotype
RNA G-quadruplexes cause neuronal dysfunction in trinucleotide CGG repeat diseases
Muscle pathology of OPDM – how to differentiate from OPMD
Neuronal intranuclear inclusion disease
Neuropathology of OPDM
AOMC Young Investigator Award Session
Sep 14（Sat.）9:00-10:30Room2
- Chair
- Shahriar Nafissi（Department of Neurology Tehran University of Medical Sciences）
- Yuh-Jyh Jong（Department of Pediatrics and Laboratory Medicine Kaohsiung Medical University Hospital）
- Ai Yamanaka（Department of Neuromuscular Research, National Center of Neurology and Psychiatry, Tokyo, Japan）
- Chiara Lai Folland（Centre for Medical Research, University of Western Australia, Harry Perkins Institute of Medical Research, Perth, Western Australia, Australia）
- Francia Victoria De Los Reyes（Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan）
- Xingyu Xia（Department of Neurology, Huashan Hospital, Fudan University, Shanghai 200040, China）
- Jeffrey Lui（Department of Paediatrics and Adolescent Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, HKSAR）
AY-1Visualization of degenerative processes of the myofibers on muscle pathology in OPDM based on single nucleus RNA-seq data
AY-2Detection of STR expansions on a neuromuscular gene panel using STRipy improves diagnostic rate of ataxia
AY-3Characterizing the Cell-Cell Interaction in Inclusion Body Myositis
AY-44qA D4Z4 methylation test as a valuable complement for differential diagnosis in patients with FSHD-like phenotype
AY-5Identification of key gene functions impaired in dystrophinopathy by transcriptomic analysis of patient-derived iPSC-cardiomyocytes
JMS Young Investigator Award Session
Sep 14（Sat.）10:40-12:30Room2
- Chair
- Yuh-Jyh Jong（Department of Pediatrics and Laboratory Medicine Kaohsiung Medical University Hospital）
- Katsuhiko Kunitake
- Alaa Elgaabari（Department of Animal and Marine Bioresource Sciences, Graduate School of Agriculture, Kyushu University, Fukuoka, Japan）
- Yosuke Hiramuki（Department of Chromosome Biomedical Engineering, School of Life Science, Faculty of Medicine, Tottori University）
- Hiroki Yamazaki（Division of Endocrinology and Metabolism, Department of Internal Medicine, Teikyo University School of Medicine）
- Mitsuru Sasaki-Honda（CiRA, Kyoto University, Japan）
- Megumi Yokomizo (Goto)（Center for iPS Cell Research and Application (CiRA), Kyoto University）
JY-1Serglycin promotes skeletal myogenesis through EZH2 degradation in satellite cells
JY-2Macrophage HGF-denitration activity: a key to youthful muscle regeneration
JY-3Generation of an FSHD1 mouse model carrying FSHD1-derived chromosome 4q35 using mouse artificial chromosome
JY-4The role of muscle glucocorticoid receptor signaling in accelerating obesity, glucose intolerance, and aging-related metabolic changes
JY-5Modeling cell type specific and sporadic DUX4 gene expression in FSHD
JY-6Establishment of Cell Transplantation Therapy Aimed at Ameliorating Ullrich Congenital Muscular Dystrophy~Exploration of Cell Sources for Transplantation~
JMS Student Award Poster Presentation Session
Sep 13（Fri.）18:30-20:30Poster Room
- Chair
- Masayuki Nakamori（Department of Neurology Yamaguchi University）
- Motoi Kanagawa（Department of Cell Biology and Molecular Medicine, Ehime University）
- Akiyoshi Uezumi（Division of cell heterogeneity of Medical Institute of Bioregulation Kyushu University）
- So-ichiro Fukada（Laboratory of Stem Cell Regeneration and Adaptation Graduate School of Pharmaceutical Sciences, Osaka University）
- Eman Elrefaei（Osaka University, Medical Biochemistry department, faculty of medicine）
- Nao Tokuda（Graduate School of Health Sciences, Sapporo Medical University, Sapporo, Japan）
- Daichi Arai（Cooperative Major of Advanced Health Science,Tokyo University of Agriculture and Technology）
- Azuma Naito（Graduate School of Health Sciences, Sapporo Medical University, Sapporo, Japan）
- Nao Yamauchi（Graduate School of Health Sciences, Sapporo Medical University, Sapporo, Japan）
- Edvinas Cerniauskas（CiRA, Kyoto University）
- Minori Suzuki（Department of Nutritional Physiology, The Medical Nutrition, Graduate School of Tokushima University）
- Mayuho Miki（Department of Clinical application, Center for iPS cell Research and Application, Kyoto University）
- Takumi Makino（Department of Applied Biological Chemistry, Graduate School of Agricultural and Life Sciences, The University of Tokyo）
- Takumi Kishimoto（Department of Clinical application, Center for iPSCs Research and Application (CiRA), Kyoto University）
- Junjie He（Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan）
- Tatsuhiro Yamaguchi（The University of Tokyo）
- Chang Chen（Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry）
JSA-1LSMEM2, localized at the neuromuscular junction, modulatesMitochondrial integration in skeletal muscles
JSA-2Satellite cells are not indispensable for repair following exercise-induced muscle damage
JSA-3Reactive oxygen species related DNA damage induced cellular senescence in myoblasts
JSA-4Overexpression of PGC-1α prevents eccentric contraction-induced muscle damage in a utrophin-independent manner
JSA-5Isometric interval training with high- but not low-intensity contractions improves fatigue resistance in dystrophin deficient muscle
JSA-6Next-generation cell and gene therapy
JSA-7Inactivation of Aconitase2 under simulated microgravity and analysis of skeletal muscle-specific Aco2-deficient mice
JSA-8Elucidation of the mechanism by which training improves the engraftment efficiency of transplanted cells in Duchenne muscular dystrophy
JSA-9BMP signaling controls skeletal muscle cell maturation
JSA-10A mechanistic analysis of epigenetic disruption in Facioscapulohumeral muscular dystrophy
JSA-11RNA-based CRISPRoff silencing to target DUX4 in Facioscapulohumeral muscular dystrophy
JSA-12Reduced expression of Dok-7 and agrin due to mechanical unloading induces acetylcholine receptor degeneration in type 1 myofibers in mice
JSA-13Elucidating the role of Oncostatin M signaling in myoblast proliferation and muscle physiology in wild-type and SOD1G93A mice
JMS Student Award Session
Sep 15（Sun.）8:00-8:50Room1
- Chair
- Hiroshi Sakai（Ehime University）
- Mikako Ito（Nagoya University Graduate School of Medicine）
※Only the Student Award candidates selected for the second round will present their research (an oral presentation) here.
Clinical Pathological Conference
Sep 15（Sun.）9:30-12:10Room2
- Chair
- Ichizo Nishino（National Center of Neurology and Psychiatry, Japan）
- Kum Thong Wong（University of Malaya, Malaysia）
Award and Closing Ceremony
Sep 15（Sun.）13:20-14:20Room1
Luncheon Seminar 1
Emerging Science in SMA Treatment for Better Outcomes
Sep 12（Thu.）12:10-13:00Room2
Sponsored by Biogen Japan Ltd.
- Chair
- Dr. Hirofumi Komaki（National Center of Neurology and Psychiatry, Japan）
- Dr. Yin-Hsiu Chien（National Taiwan University Hospital, Taiwan）
- Dr. Takashi Nakajima（NHO Niigata National Hospital, Japan）
LS1-1Clinical Experience of Spinal Muscular Atrophy in the Era of Newborn Screening and Treatment
LS1-2Neurofeedback rehabilitation using robot-suits hybrid assistive limb (HAL)
Luncheon Seminar 2
Sep 13（Fri.）12:30-13:20Room1
Sponsored by Alexion Pharma G.K Medical Affairs Division
- Chair
- Prof. Ichizo Nishino（Department of Neuromuscular Research National Institute of Neuroscience, National Center of Neurology and Psychiatry, Japan）
- Dr. Kimitoshi Kimura（Department of Neurology, Graduate school of Medicine and Faculty of Medicine, Kyoto University, Japan）
LS2Long-Term Treatment Strategies for Myasthenia Gravis
Luncheon Seminar 3
Generalized Myasthenia Gravis Seminar -Entering a New Stage -
Sep 13（Fri.）12:30-13:20Room2
Sponsored by UCB Japan Co. Ltd.
- Chair
- Dr. Kazuma Sugie（Professor & Chairman of Department of Neurology Nara Medical University, Japan）
- Dr. Hiroyuki Murai（Professor and Chairman of Department of Neurology, International University of Health and Welfare, Japan）
LS3The Forefront of gMG Treatment - Positioning of Subcutaneous Injections -
Sponsored Symposium
Multidisciplinary Approach to Muscular Dystrophy Management
Sep 13（Fri.）15:30-16:40Room2
Sponsored by Pfizer Japan Inc.
- Chair
- Dr. Hirofumi Komaki（Director, Translational Medical Center, National Center of Neurology and Psychiatry, Japan）
- Dr. Keiko Ishigaki（Associate Professor, Department of Pediatrics, Tokyo Women's Medical University School of Medicine, Japan）
- Dr. Mi Kyoung Song（Associate Professor, Pediatrics, Seoul National University Hospital, Korea）
- Dr. Harumasa Nakamura（Director, Department of Clinical Research Support, National Center of Neurology and Psychiatry, Japan）
- Dr. Jong-Hee Chae（Professor, Pediatrics, Seoul National University Hospital, Korea）
SS1Motor Function Assessment in the Treatment of Muscular Dystrophy
SS2Cardiac Management of the Patient with Muscular Dystrophy
SS3Usefulness of Japanese National Registry of Muscular Dystrophy (Remudy)
SS4Multidisciplinary Approach to Management of Muscular Dystrophy Treatment in Korea
Morning Seminar
Exploring Neu-REFIX Beta Glucans: Mechanisms and Effects in Reducing Muscle Fibrosis and Fatigue.
Sep 14（Sat.）8:00-8:50Room1
Sponsored by GN Corporation Co Ltd, Japan
- Chair
- Prof. Masaru Iwasaki（Vice-President, University of Yamanashi, Kofu, Japan）
- Dr. Yoshitsugu Aoki（Head, Department of Molecular Therapy, National Center for Neurology and Psychiatry (NCNP), Tokyo, Japan）
MSOral administration of Neu-REFIX Beta 1,3-1,6 Glucans reduces skeletal muscle fibrosis and fatigue in dystrophic mice.
Luncheon Seminar 4
The diagnosis and treatment of treatable childhood-onset neuromuscular diseases.
Sep 14（Sat.）12:35-13:25Room1
Sponsored by CHUGAI PHARMACEUTICAL CO., LTD.
- Chair
- Dr. Hiroyuki Awano（Research Initiative Center, Organization for Research Initiative and Promotion, Tottori University, Japan）
- Dr. Keiko Ishigaki（Associate Professor, Department of Pediatrics Tokyo Women's Medical University, School of Medicine, Japan）
LS4The diagnosis and treatment of treatable childhood-onset neuromuscular diseases.
Luncheon Seminar 5
Treatment Strategies for Generalized Myasthenia Gravis
Sep 15（Sun.）12:20-13:10Room1
Sponsored by argenx Japan K.K.
- Chair
- Prof. Masanori Takahashi（Lab of Clinical Neurophysiology, Dept. Clinical Laboratory and Biomedical Sciences, Osaka University Graduate School of Medicine, Japan）
- Dr. Shigeaki Suzuki（Department of Neurology, Keio University School of Medicine, Japan）
- Dr. Akitoshi Takeda（Department of Neurology, Osaka Metropolitan University, Japan）
LS5-1Clinical impact of efgartigimod, the first approved anti-neonatal Fc receptor inhibitor for MG in Japan.
LS5-2Efgartigimod therapy in patients with myasthenia gravis of working age: challenges encountered by patients with MG at work and when caring for children.
Luncheon Seminar 6
Updates on GNE Myopathy Treatment in Japan
Sep 15（Sun.）12:20-13:10Room2
Sponsored by Nobelpharma Co., Ltd
- Chair
- Prof. Ichizo Nishino（National Center of Neurology and Psychiatry, Japan）
- Dr. Wakako Yoshioka（National Center of Neurology and Psychiatry, Japan）
- Dr. Naoki Suzuki（Tohoku University Graduate School of Medicine, Japan）
LS6-1Recent Insights into GNE Myopathy: Genotype-Phenotype Correlations, Disease Progression, and Therapeutic Approaches Beyond Sialic Acid Supplementation
LS6-2A New Era in the Treatment of Distal Myopathy: Expectations and Future Prospects for Aceneuramic acid
※Please provide your assigned Abstract Code when you apply for the Poster Printing Service.